G6PD and breast carcinoma: They identified cross-reactivity between anti-Setaria equina antibodies and cell extracts from Huh-7 hepatoma and MCF-7 human breast cancer cells at 75 and 70 kDa, potentially corresponding to Glucose-6-phosphate dehydrogenase and HSP-70, respectively [111].